Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cervical cancer (cervix uteri)

N Einhorn

    Acta Oncologica (Stockholm, Sweden)
    |January 1, 1996
    PubMed
    Summary

    Radiotherapy is the primary treatment for cervical cancer due to organ tolerance. Advanced stages and certain early-stage findings necessitate radiotherapy, with high-dose rate brachytherapy showing economic advantages.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Gain of chromosome 3q is an early and consistent genetic aberration in carcinomas of the vulva.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2005
    Same author

    Laminin-5 gamma 2 chain as an invasivity marker for uni- and multifocal lesions in the lower anogenital tract.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2002
    Same author

    Phase II study of mitomycin-C and cisplatin in disseminated, squamous cell carcinoma of the uterine cervix. A European Organization for Research and Treatment of Cancer (EORTC) Gynecological Cancer Group study.

    European journal of cancer (Oxford, England : 1990)·2001
    Same author

    D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study.

    Anti-cancer drugs·2001
    Same author

    Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

    Lancet (London, England)·2001
    Same author

    Long-term follow-up of the Stockholm screening study on ovarian cancer.

    Gynecologic oncology·2000

    Area of Science:

    • Gynecologic Oncology
    • Radiation Oncology
    • Medical Physics

    Background:

    • Cervical cancer treatment relies heavily on radiotherapy due to favorable pelvic anatomy and organ radiation tolerance.
    • Surgery is reserved for very early stages, but postoperative radiotherapy is indicated for more advanced findings or lymph node metastasis.
    • Advanced cervical cancer is generally treated with radiotherapy alone.

    Purpose of the Study:

    • To synthesize current literature on radiotherapy for cervical cancer (cervix uteri).
    • To review treatment modalities including surgery, radiotherapy, and emerging combination therapies.
    • To compare intracavitary brachytherapy techniques: low-dose rate (LDR) and high-dose rate (HDR).

    Main Methods:

    • Literature synthesis based on 59 scientific articles.
    • Included 8 randomized studies, 1 prospective study, and 36 retrospective studies.
    • Analysis encompassed 34,024 patients.

    Main Results:

    • Radiotherapy is the dominant treatment for cervical cancer.
    • High-dose rate (HDR) brachytherapy appears more economically favorable than low-dose rate (LDR) therapy.
    • Further research is needed on potential long-term complications associated with HDR therapy.

    Conclusions:

    • Radiotherapy is the standard of care for cervical cancer, particularly for advanced stages.
    • Combination therapies (radiotherapy with chemotherapy and/or surgery) are under investigation.
    • HDR brachytherapy offers economic benefits, but its long-term safety profile requires further study.

    Related Experiment Videos